30
Participants
Start Date
October 13, 2021
Primary Completion Date
November 5, 2022
Study Completion Date
January 5, 2023
domestic polysaccharide superparamagnetic iron oxide nanoparticle
Patients will receive contrast-enhanced cardiac magnetic resonance with polysaccharide superparamagnetic iron oxide nanoparticle before percutaneous coronary angiography.Patients received intravenous polysaccharide superparamagnetic iron oxide nanoparticle before magnetic resonance imaging.
First Affiliated Hospital of Nanjing Medical University, Nanjing
Collaborators (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY
The First Affiliated Hospital with Nanjing Medical University
OTHER